These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Blood serum levels of amino-terminal pro-C-type natriuretic peptide in patients with rheumatoid arthritis. Olewicz-Gawlik A; Trzybulska D; Grala P; Hrycaj P Adv Med Sci; 2010; 55(2):261-5. PubMed ID: 20934962 [TBL] [Abstract][Full Text] [Related]
12. Circulating E-selectin and tumor necrosis factor-alpha in extraarticular involvement and joint disease activity in rheumatoid arthritis. Corona-Sanchez EG; Gonzalez-Lopez L; Muñoz-Valle JF; Vazquez-Del Mercado M; Lopez-Olivo MA; Aguilar-Chavez EA; Salazar-Paramo M; Loaiza-Cardenas C; Oregon-Romero E; Navarro-Hernandez RE; Gamez-Nava JI Rheumatol Int; 2009 Jan; 29(3):281-6. PubMed ID: 18726101 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study. van Leeuwen MA; Westra J; Limburg PC; van Riel PL; van Rijswijk MH Ann Rheum Dis; 1995 Aug; 54(8):674-7. PubMed ID: 7677445 [TBL] [Abstract][Full Text] [Related]
14. Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients. Galil SM; El-Shafey AM; Hagrass HA; Fawzy F; Sammak AE Int J Rheum Dis; 2016 Apr; 19(4):377-84. PubMed ID: 25292349 [TBL] [Abstract][Full Text] [Related]
15. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994 [TBL] [Abstract][Full Text] [Related]
16. Cellular and humoral markers of systemic inflammation in acute reactive arthritis and early rheumatoid arthritis. Kuuliala A; Takala A; Siitonen S; Leirisalo-Repo M; Repo H Scand J Rheumatol; 2004; 33(1):13-8. PubMed ID: 15124937 [TBL] [Abstract][Full Text] [Related]
17. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis. Ertenli I; Kiraz S; Arici M; Haznedaroglu IC; Calgüneri M; Celik I; Kirazli S J Rheumatol; 1998 Jun; 25(6):1054-8. PubMed ID: 9632062 [TBL] [Abstract][Full Text] [Related]
18. Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy. Salih AM; Nixon NB; Dawes PT; Mattey DL J Rheumatol; 1999 Mar; 26(3):551-5. PubMed ID: 10090161 [TBL] [Abstract][Full Text] [Related]
19. Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study. Ma JD; Wei XN; Zheng DH; Mo YQ; Chen LF; Zhang X; Li JH; Dai L Arthritis Res Ther; 2015 Oct; 17():289. PubMed ID: 26467222 [TBL] [Abstract][Full Text] [Related]
20. Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study. Ponthieux A; Herbeth B; Droesch S; Haddy N; Lambert D; Visvikis S Atherosclerosis; 2004 Feb; 172(2):299-308. PubMed ID: 15019540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]